Generic Review
Find basic omissions in one document.
The intelligence behind every release
Beyond AI
document review.
Quality intelligence
built for every lot.
Generic AI reads a file. LotVanta understands GMP, your procedures, your history, and the entire release process.
LLotVanta
Batch 10045On Track97%ready
- GMP context applied
- SOPs and specifications checked
- Lot history connected
- Release workflow traceable
CONNECTED INTELLIGENCE
GENERIC AI
Useful for a document.
- 01One file at a time
- 02Generic findings
- 03No company memory
- 04No controlled release workflow
VS
LOTVANTA
Built for the decision.
- ✓GMP and regulatory context
- ✓Company SOPs and specifications
- ✓Connected lot and quality history
- ✓Traceable human-controlled release
The LotVanta advantage
From reading documents
to understanding Quality.
The strongest value begins when intelligence becomes company-specific, connected, and predictive.
GMP Expert
Connect findings to applicable quality expectations.
Company Knowledge
Apply your SOPs, specifications, forms, and criteria.
Connected Memory
Use prior lots, deviations, CAPAs, equipment, and trends.
Enterprise Release
Review the complete manufacturing and release story.
Predictive Quality
Surface emerging risk before it becomes a deviation.
DOCUMENT REVIEWQUALITY INTELLIGENCE
One complete release story
Connected Batch Intelligence
LotVanta does not review an isolated result. It brings the evidence surrounding the lot into one decision-ready view.
▤Batch Record
◇Raw Materials
♙Training
⌁Equipment
♨Environmental Monitoring
◉CELL THERAPY LOTBatch 10045Connected & traceable
◎Chain of Identity
✣Sterility
◈Potency
△Deviations / CAPAs
✓Release Decision
The vision
Move from detecting risk
to anticipating it.
Connected data can help Quality recognize patterns earlier, focus attention where it matters, and act before small signals become costly deviations.
Predictive insights support—not replace—qualified human Quality decisions.97%
Release readiness63%
Deviation riskNewly trained operatorHigh
Supplier quality trendMedium
Incubator #3 historyMedium
Cell viability declineLow
Why companies invest
They are not paying for AI.
They are paying for better outcomes.
Faster release
Reduce document review from days to focused decisions.
Lower regulatory risk
Apply GMP expectations consistently across every lot.
Consistent review
Standardize decisions across sites, products, and reviewers.
Audit readiness
Keep traceability from source document to final disposition.
Institutional knowledge
Preserve company expertise as people and processes change.
✓
CONFIDENCE AT THE POINT OF RELEASE